Guoshun Luo

6PUBLICATIONS
2CO-AUTHORS
Molecular targetsBiologically active moleculesAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 10, 2026
Optimization of a Second-Generation, Highly Selective Polθ/PARP1 Dual Inhibitor with Improved Pharmacokinetics and Potent Activity against HR-Deficient Tumors.

|Jan 06, 2026
Approved Steroidal Drugs (2000-2025): A Medicinal Chemistry Perspective.

Jiacheng Zhu, Guoshun Luo, Hua Xiang

|Mar 21, 2025
Discovery of a Highly Potent and Selective Tyrosine Kinase 2 (TYK2) Degrader with In Vivo Therapeutic Efficacy in a Murine Psoriasis Model.

Shuangshuang Xiong, Jiaqi Yang, Ming Yang

|Oct 09, 2024
Targeting Protein Kinase, Membrane-Associated Tyrosine/Threonine 1 (PKMYT1) for Precision Cancer Therapy: From Discovery to Clinical Trial.

Ming Yang, Hua Xiang, Guoshun Luo

|Mar 21, 2024
Structure-Activity Relationship (SAR) Studies of Novel Monovalent AR/AR-V7 Dual Degraders with Potent Efficacy against Advanced Prostate Cancer.

Maoxu Xiao, Si Ha, Jiacheng Zhu

|Feb 20, 2024
Discovery and Proof of Concept of Potent Dual Polθ/PARP Inhibitors for Efficient Treatment of Homologous Recombination-Deficient Tumors.

Luyu Ma, Wei Chen, Ming Yang

Pageof 1

Frequent Collaborators

6 joint publications

Hua Xiang

1 joint publications

Chenxuan Ji